These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31388568)

  • 1. Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module.
    Patel E; Tsang Y; Baker A; Callender J; Hafeez S; Hall E; Hansen VN; Lewis R; McNair H; Miles E; Huddart R
    Clin Transl Radiat Oncol; 2019 Nov; 19():27-32. PubMed ID: 31388568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Development of Therapeutic Radiographers in Imaging and Adaptive Radiotherapy Through Clinical Trial Quality Assurance.
    Webster A; Hafeez S; Lewis R; Griffins C; Warren-Oseni K; Patel E; Hansen VN; Hall E; Huddart R; Miles E; McNair HA
    Clin Oncol (R Coll Radiol); 2021 Jul; 33(7):461-467. PubMed ID: 33766503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer.
    Webster A; Francis M; Gribble H; Griffin C; Hafeez S; Hansen VN; Lewis R; McNair H; Miles E; Hall E; Huddart R;
    Radiother Oncol; 2024 Oct; 199():110460. PubMed ID: 39069085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognising the challenges of implementing multi-centre adaptive plan of the day radiotherapy.
    Webster A; McNair HA; Hansen VN; Lewis R; Patel E; Miles E; Hall E; Hafeez S; Huddart R;
    Tech Innov Patient Support Radiat Oncol; 2022 Mar; 21():31-35. PubMed ID: 35198744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.
    Wills L; Maggs R; Lewis G; Jones G; Nixon L; Staffurth J; Crosby T;
    Radiat Oncol; 2017 Nov; 12(1):179. PubMed ID: 29141663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01).
    Kron T; Pham D; Roxby P; Rolfo A; Foroudi F
    Radiother Oncol; 2012 Jun; 103(3):293-8. PubMed ID: 22483676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study.
    Middleton M; Frantzis J; Healy B; Jones M; Murry R; Kron T; Plank A; Catton C; Martin J
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1576-81. PubMed ID: 21074334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer.
    Huddart R; Hafeez S; Lewis R; McNair H; Syndikus I; Henry A; Staffurth J; Dewan M; Vassallo-Bonner C; Moinuddin SA; Birtle A; Horan G; Rimmer Y; Venkitaraman R; Khoo V; Mitra A; Hughes S; Gibbs S; Kapur G; Baker A; Hansen VN; Patel E; Hall E;
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):412-424. PubMed ID: 33316362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era for clinical trial quality assurance: A credentialing programme for RTT led adaptive radiotherapy.
    Tsang Y; Baker A; Patel E; Miles E
    Tech Innov Patient Support Radiat Oncol; 2018 Mar; 5():1-2. PubMed ID: 32095567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials.
    Cui Y; Galvin JM; Parker W; Breen S; Yin FF; Cai J; Papiez LS; Li XA; Bednarz G; Chen W; Xiao Y
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):271-7. PubMed ID: 22541964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.
    Hafeez S; Webster A; Hansen VN; McNair HA; Warren-Oseni K; Patel E; Choudhury A; Creswell J; Foroudi F; Henry A; Kron T; McLaren DB; Mitra AV; Mostafid H; Saunders D; Miles E; Griffin C; Lewis R; Hall E; Huddart R
    BMJ Open; 2020 Dec; 10(12):e041005. PubMed ID: 33384390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image guided adaptive external beam radiation therapy for cervix cancer: Evaluation of a clinically implemented plan-of-the-day technique.
    Buschmann M; Majercakova K; Sturdza A; Smet S; Najjari D; Daniel M; Pötter R; Georg D; Seppenwoolde Y
    Z Med Phys; 2018 Aug; 28(3):184-195. PubMed ID: 29031916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.
    Acharya S; Fischer-Valuck BW; Kashani R; Parikh P; Yang D; Zhao T; Green O; Wooten O; Li HH; Hu Y; Rodriguez V; Olsen L; Robinson C; Michalski J; Mutic S; Olsen J
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):394-403. PubMed ID: 26678659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POD-DOSI: A dedicated dosimetry system for GammaPod commissioning and quality assurance.
    Parsons D; Zhang Y; Gu X; Lu W
    Med Phys; 2020 Aug; 47(8):3647-3657. PubMed ID: 32367556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer.
    Groom N; Wilson E; Lyn E; Faivre-Finn C
    Br J Radiol; 2014 May; 87(1037):20130653. PubMed ID: 24620839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.
    Clark CH; Miles EA; Urbano MT; Bhide SA; Bidmead AM; Harrington KJ; Nutting CM;
    Br J Radiol; 2009 Jul; 82(979):585-94. PubMed ID: 19332518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Radiographers at the Helm: Moving Towards Radiographer-Led MR-Guided Radiotherapy.
    Hales RB; Rodgers J; Whiteside L; McDaid L; Berresford J; Budgell G; Choudhury A; Eccles CL
    J Med Imaging Radiat Sci; 2020 Sep; 51(3):364-372. PubMed ID: 32600981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and quality assurance of an image-guided radiation therapy system for intensity-modulated radiation therapy radiotherapy.
    Tsai JS; Micaily B; Miyamoto C
    Med Dosim; 2012; 37(3):321-33. PubMed ID: 22417899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (Trans-Tasman Radiation Oncology Group 10.01): Lessons learned.
    Pham D; Roxby P; Kron T; Rolfo A; Foroudi F
    J Med Phys; 2013 Apr; 38(2):59-66. PubMed ID: 23776308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Adaptive Margins Using a Single Planning Computed Tomography Scan for Bladder Radiotherapy.
    Canlas R; McVicar N; Nakano S; Sahota H; Mahajan P; Tyldesley S
    J Med Imaging Radiat Sci; 2016 Sep; 47(3):227-234. PubMed ID: 31047287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.